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Abstract Frataxin deWciency in Friedreich’s ataxia
(FRDA) causes cardiac, endocrine, and nervous system
manifestations. Frataxin is a mitochondrial protein, and
adequate amounts are essential for cellular iron homeosta-
sis. The main histological lesion in the brain of FRDA
patients is neuronal atrophy and a peculiar proliferation of
synaptic terminals in the dentate nucleus termed grumose
degeneration. This cerebellar nucleus may be especially
susceptible to FRDA because it contains abundant iron.
We examined total iron and selected iron-responsive pro-
teins in the dentate nucleus of nine patients with FRDA
and nine normal controls by biochemical and micro-
scopic techniques. Total iron (1.53 § 0.53 mol/g wet
weight) and ferritin (206.9 § 46.6 g/g wet weight) in
FRDA did not signiWcantly diVer from normal controls
(iron: 1.78 § 0.88 mol/g; ferritin: 210.9 § 9.0 g/g) but
Western blots exhibited a shift to light ferritin subunits.
Immunocytochemistry of the dentate nucleus revealed loss
of juxtaneuronal ferritin-containing oligodendroglia and
prominent ferritin immunoreactivity in microglia and astro-
cytes. Mitochondrial ferritin was not detectable by immu-
nocytochemistry. Stains for the divalent metal transporter 1
conWrmed neuronal loss while endothelial cells reacting
with antibodies to transferrin receptor 1 protein showed
crowding of blood vessels due to collapse of the normal
neuropil. Regions of grumose degeneration were strongly
reactive for ferroportin. Purkinje cell bodies, their dendrites
and axons, were also ferroportin-positive, and it is likely
that grumose degeneration is the morphological manifesta-
tion of mitochondrial iron dysmetabolism in the terminals
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Introduction
The mutation in Friedreich’s ataxia (FRDA) [3] causes
defective transcription of the frataxin gene resulting in mod-
erate to severe loss of frataxin protein. This mitochondrial
protein is essential for cellular iron homeostasis though its
detailed role in this process has not yet been conclusively
established. Friedreich’s ataxia is a complex disease, aVect-
ing the peripheral and central nervous systems, the heart, and
the insulin-producing beta cells of the pancreas. In the brain,
the dentate nuclei are almost invariably atrophic. This lesion
in the cerebellum of patients with FRDA was at Wrst not fully
appreciated because of emphasis on spinal cord and dorsal
root ganglia. Atrophy of the dentate nucleus is often severe,
combining neuronal loss and a peculiar proliferation of syn-
aptic terminals termed “grumose” degeneration [13–14]. It
has become apparent that the severe ataxia of FRDA patients
is not solely due to destruction of the ganglia of dorsal spinal
roots, the dorsal nuclei of Clarke, and speciWc long Wber
tracts of the spinal cord. Ataxia must also be attributed to
dysfunction of the dentate nuclei [24, 25, 30]. Mitochondrial
iron excess in FRDA is most apparent in the heart [19, 22],
and reduced activity of iron-sulfur cluster-dependent com-
plexes I–III of the electron transport chain, aconitase [26],
and ferrochelatase [33] may reXect iron-catalyzed oxidative
injury to mitochondria. It is unknown whether the high iron
concentration in the human dentate nucleus makes this struc-
ture especially vulnerable in FRDA. Several other iron-rich
gray matter structures in the brain, such as globus pallidus,
substantia nigra, red nucleus, and subthalamic nucleus escape
damage in this disease. The study presented here revealed
distinct changes in several iron-responsive proteins, that is,
ferritin, divalent metal transporter 1 (DMT1), transferrin
receptor 1 (TfR1), and ferroportin. Ferroportin [1, 4, 21] is
critical in the export of iron from the cytoplasm of many cell
types and may be involved in the modiWcation of corticonu-




Fixed and frozen autopsy tissues of nine patients with
FRDA were obtained through tissue donations to the
National Ataxia Foundation, Minneapolis, MN, USA, and
the Friedreich’s Ataxia Research Alliance, Alexandria, VA,
USA (Table 1). Control samples came from the autopsy
practice at the Veterans AVairs Medical Center in Albany,
NY, USA. Numerous additional paraYn-embedded sam-
ples of cerebellar cortex and dentate nucleus were made
available by the Canadian Association of Friedreich’s
Ataxia Tissue Bank, Department of Pathology, Centre
Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC,
Canada, and collaborating neuropathologists in the United
States, Canada, and Germany. The diagnosis of FRDA was
Table 1 Iron and ferritin concentrations in the dentate nucleus of Friedreich’s ataxia
FRDA Friedreich’s ataxia, GAA, guanine-adenine-adenine trinucleotide repeats
a
 Mean § SD, b  nine normal controls, c  45 normal dentate nuclei from reference [8] after conversion from 10.35 mg iron/100 g to 1.85 mol/g
wet weight
No. Sex Age of onset 
(year)










FRDA 1 F 7 38 750 594 0.65 210.0
FRDA 2 F 15 33 604 455 1.90 201.1
FRDA 3 F 8 23 777 582 1.17 280.6
FRDA 4 M 16 39 491 370 2.40 225.8
FRDA 5 M 13 20 850 850 1.27 208.6
FRDA 6 F 19 79 549 356 1.28 208.8
FRDA 7 F 30 75 631 242 1.98 209.1
FRDA 8 F 8 28 709 559 1.38 100.0
FRDA 9 F 9 26 850 690 1.78 217.8
All FRDA – 7–30 23–79 – – 1.53 § 0.53a 206.9 § 46.6a
Normalb M/F – 52–80 – – 1.78 § 0.88a 210.9 § 9.0a
Normalc M/F – 30–100 – – 1.85 § 0.87a –123
Acta Neuropathol (2007) 114:163–173 165based on the classical neuropathological phenotype and
conWrmation of homozygous GAA expansion in deoxyribo-
nucleic acid extracted from frozen tissue [5] (Table 1).
Biochemical methods
These techniques were described in detail in a prior publi-
cation on FRDA heart [22] and are summarized here as fol-
lows: for the assay of total iron, a portion of the dentate
nucleus was dissected from sliced cerebellum, weighed,
and lyophilized in Kjeldahl Xasks. The tissue samples were
fully oxidized by heating in 10 M sulfuric acid and hydro-
gen peroxide. Inorganic iron in the digest was assayed col-
orimetrically with ferrozine, and results were expressed as
mol iron/g wet weight. For the assay of holoferritin by
“double-sandwich” enzyme-linked immunosorbent assay
(ELISA), dissected samples of dentate nucleus were
homogenized by ultrasonication in 0.05 M Tris buVer (pH
7.6) containing a protease-inhibitor “cocktail”, heat-treated,
and centrifuged to obtain a clear supernatant. Polystyrene
ELISA plates were coated at pH 9.6 with monoclonal
anti-human ferritin (Fitzgerald Industries International,
Concord, MA, USA). The supplier of this antibody does
not specify the antigenic determinant on the holoferritin
molecule. It reacts vigorously with puriWed human ferritin
on double immunodiVusion but not with separated heavy
(H) or light (L) ferritin subunits on Western blots. Diluted
aliquots of the ferritin-containing supernatants were applied
to the pre-coated ELISA plates and allowed to react with
the antibody. The next step was application of a rabbit
polyclonal anti-ferritin, followed by horseradish peroxi-
dase-conjugated anti-rabbit IgG. After color development
with ortho-phenylenediamine and hydrogen peroxide,
absorbances at 492 nm were compared to those of a com-
mercial human heart ferritin standard (Lee Biosolutions,
St Louis, MO, USA). Results were expressed as g holo-
ferritin/g wet weight.
For sodium dodecylsulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and Western blotting, the heat-
treated supernatants were concentrated by centrifugation
through ultraWltration membranes with a molecular cut-oV
of 100 kDa as described before [22]. After dissociation in
sample buVer, they were electrophoresed through gels
containing 4 M urea. Proteins were electro-blotted onto
polyvinyledene Xuoride (PVDF) membranes, and H- and
L-ferritin subunits were detected immunochemically with a
mixture of rabbit anti-human liver ferritin (Immunology
Consultant Labs, Newberg, OR, USA) and anti-human
H-ferritin subunit (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). The relative contributions of H- and L-ferritin
subunits to holoferritin in FRDA and normal dentate gray
matter were estimated by densitometry and expressed as an
H/L ratio for each specimen.
Immunocytochemistry, lectin aYnity cytochemistry, 
and immunoXuorescence
Sections were prepared from paraYn-embedded or sucrose-
inWltrated tissue blocks to achieve immunocytochemical
detection of ferritin; mitochondrial ferritin; ferroportin; two
isoforms of DMT1 [6]; TfR1 (CD71); synaptosome-associ-
ated protein 25 (SNAP-25); CD45; glial Wbrillary acidic pro-
tein (GFAP); mitochondrial complex V (F1Fo¡); and class
III -tubulin. Table 2 lists antisera and antibodies, their
sources, and embedding, sectioning, and antigen retrieval
techniques. Results obtained with anti-CD45 (for microglia)
were augmented by lectin aYnity cytochemistry with bioti-
nylated Ricinus communis agglutinin 1 (RCA-1) (Table 2).
To conWrm the speciWcity of ferroportin immunoreactivity in
sections from human brain, two diVerent antibodies raised
against mouse ferroportin-speciWc peptides were available
[1, 11]. Also, diluted anti-ferroportin solutions were pre-
incubated for 4 h at 4°C in a 20-fold excess (by peptide
weight/vol) of a ferroportin-speciWc peptide [11] or a lysate
of human embryonic kidney (HEK) cells transfected to
overexpress ferroportin [11]. Lysates of HEK293T cells
transfected with empty vector only were used as controls.
2-Mercaptoethanol and SDS in the cell lysates were
removed by centrifugation through membranes with a
molecular-weight cut-oV of 10,000 (Ultrafree-0.5, Millipore,
Billerica, MA, USA), followed by washing of the retained
proteins with phosphate-buVered saline (PBS). Protein con-
centrations of diluted antibodies and RCA-1 were optimized
empirically to 0.1–10 g/ml. Dewaxing of 6 m-thick par-
aYn sections, oxidation by 3% hydrogen peroxide in metha-
nol, rehydration, background suppression with 10% normal
horse serum and 4% bovine serum albumin (BSA), dehydra-
tion after completion of immunocytochemical steps, and
mounting in xylene-soluble medium followed standard pro-
tocols. Positive-contrast immunocytochemistry consisted
of the sequential incubation in primary antibody in PBS
containing 1% normal horse serum (by vol) and 4% BSA
(weight/vol), a biotinylated secondary antibody in PBS, and
diluted horseradish peroxidase (HRP)-labeled streptavidin in
PBS (2 g/ml; Sigma, St Louis, MO, USA). For lectin aYn-
ity cytochemistry, slides were incubated in biotinylated
RCA-1 (0.05 M Tris buVer containing 1 mM CaCl2),
followed by HRP-streptavidin. The Wnal step for immunocy-
tochemistry and lectin aYnity cytochemistry was immersion
in a solution of diaminobenzidine (0.05%) and hydrogen
peroxide (0.015%) in 0.05 M Tris buVer (pH 7.6). Light
reaction product was enhanced by a 5 s-exposure of the
sections to 1% osmium tetroxide in PBS (pH 7.4).
Double-label immunoXuorescence on vibratome sections
has been described in detail elsewhere [17]. BrieXy, the
40 m-thick Xoating sections were oxidized with sodium
metaperiodate, reduced by sodium borohydride, and123










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Acta Neuropathol (2007) 114:163–173 167permeabilized with dimethylsulfoxide. Subsequent steps
included incubation in “suppressor serum” [10% normal
horse serum (by vol) containing 4% BSA (weight/vol) and
0.1% octyl phenol ethoxylate (Triton X-100/ by vol)],
immersion in primary antiserum (antibodies), and applica-
tion of biotinylated secondary antibodies (to mouse or rabbit
IgG, depending on the species of origin of the primary anti-
body). The sections were then incubated with DyeMer-
labeled streptavidin (Molecular Probes, Eugene, OR, USA).
DyeMer, the Xuorophore of the conjugate, absorbs incident
blue laser light maximally at 488 nm and Xuoresces at a
peak emission of 605 nm. After washing, the sections were
again immersed in suppressor serum and exposed to the sec-
ond antiserum or antibody, followed by Xuorescein isothio-
cyanate (FITC)-labeled anti-IgG of the species producing
the primary antibody. The sections were mounted on glass
slides in an aqueous medium (PermaXuor; Immunon, Pitts-
burgh, PA, USA) and viewed in a confocal microscope
(Meridian Insight, Okemos, MI, USA). Simultaneous emis-
sions were recorded at Wlter settings of 530 § 30 nm for
FITC and 605 nm (long pass) for DyeMer.
Results
Macroscopic iron stains
Figure 1 shows a comparison of the dentate nuclei in FRDA
(Fig. 1a) and in a normal person (Fig. 1b) after macroscopic
staining for iron with Perls’s reagents (an aqueous solution of
1% hydrochloric acid and 1% potassium ferrocyanide). In
FRDA, the normal meandering gray matter ribbon of the
nucleus is indistinct, and the stain suggests loss of iron.
Biochemical assays
Quantitative assay of total iron shows no diVerence
between nine FRDA patients and nine normal controls
(Table 1). The iron content in control specimens is identical
to the levels reported by Hallgren and Sourander [8].
Table 1 also shows the holoferritin levels in the dentate
nucleus in FRDA and normal persons. They are not signiW-
cantly diVerent but electrophoretic separation of heavy (H)
and light (L) ferritin subunits by SDS-PAGE in 4 M urea,
and Western blotting, suggest a shift to a higher contribu-
tion of L-subunits to holoferritin in FRDA when compared
with the normal extract (N in Fig. 2). Greater density of the
L-subunit reaction product is distinctly visible in lanes 3, 4,
7, and 8. Lanes 1–8 correspond to FRDA cases 1–8 in
Table 1 but band densities cannot be directly compared
with the amounts of holoferritin due to somewhat variable
recovery after membrane ultraWltration (see Materials and
methods). In case FRDA 9, insuYcient wet tissue was
available for SDS-PAGE. Densitometry reveals H/L ratios
in normal dentate nucleus that range from 1.29 to 19.7
[10.5 § 6.5 (mean § standard deviation)]. The comparable
H/L ratio for FRDA is 2.9 § 0.9 (range 0.58–4.8). The
diVerence is signiWcant by analysis of variance ( = 0.05).
Fig. 1 Macroscopic iron stain-
ing of the dentate nucleus. 
a FRDA, b Normal. Fixed slices 
of cerebellum were immersed in 
Perls’s solution of 1% potassium 
ferrocyanide in 1% hydrochloric 
acid. The dentate nucleus in 
FRDA (a) is much smaller than 
that in the normal specimen (b). 
It lacks the distinct gray matter 
ribbon of the normal nucleus, 
and the intensity of the iron 
staining is lower than normal
Fig. 2 Western blot of L- and H-ferritin subunits. Ferritin subunits in
the extracts of the dentate nucleus of eight FRDA cases were separated
by SDS-PAGE in the presence of 4 M urea, electroblotted onto PVDF
membranes, and visualized by immunochemical reactions. All sample
lanes (N, 1–8) were loaded with extract of the same amount of wet tis-
sue (2.5 mg). The location of the subunits on the blots was identiWed
by comparison with heart ferritin (HF, H-ferritin rich) and liver ferritin
(LF, L-ferritin rich). Lane N shows the relative density of the H- and
L-units in an extract of a normal dentate nucleus. Lanes 1–8 correspond
to cases 1–8 in Table 1. The relative density of L-subunits is visibly in-
creased in lanes 3, 4, 7, and 8 of the FRDA cases when compared to
the normal state (N). Densitometry shows a signiWcant decline of the
H/L ratios in the eight cases of FRDA when compared to nine normal
controls123
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and lectin aYnity cytochemistry
Figure 3a–f illustrates the changes in the cellular localiza-
tion of ferritin in the dentate nucleus of FRDA patients. The
normal dentate nucleus displays cells with intense cytoplas-
mic ferritin reaction product in juxtaneuronal cells that may
be interpreted as oligodendroglia (Fig. 3b). They are non-
reactive with anti-CD45 or RCA-1. The dentate nucleus in
FRDA (Fig. 3a) shows severe neuronal loss, and ferritin-
reactive cells have the morphology, immuno-phenotype
(CD45) (Fig. 3a, lower inset), and lectin aYnity of microglia
(RCA-1) (Fig. 3a, upper inset). Some of the CD45-reactive
cells are hypertrophic (Fig. 3a, lower inset). Double-label
immunoXuorescence in Fig. 3d, f shows the close proximity
of ferritin-reactive oligodendroglia (arrows in Fig. 3d, f) to
normal neuronal cell bodies. In FRDA (Fig. 3c), the TUJ-1
antibody conWrms the total loss of class III--tubulin in the
Fig. 3 Immunocytochemistry, lectin aYnity cytochemistry, and
immunoXuorescence of the dentate nucleus in FRDA and normal con-
trols. Left panel (a, c, e), FRDA; right panel (b, d, f), normal. Immu-
nocytochemistry and lectin aYnity cytochemistry: Ferritin-reactive
cells have the morphology of microglia (a). The upper inset in a dis-
plays lectin (RCA-1) aYnity in microglia; the lower inset in a shows
microglial hypertrophy in two cells that are immunoreactive with anti-
CD45. Ferritin immunoreactivity in the normal dentate nucleus occurs
mostly in juxtaneuronal oligodendroglia (b). These cells are RCA-1
and CD45 negative (not illustrated). Double-label confocal immuno-
Xuorescence for class III -tubulin and ferritin: Antibody TUJ-1 to
class III -tubulin shows a normal neuron (N) in an intense red color
and ferritin as green or yellow reaction product. The arrow points to a
juxtaneuronal ferritin-reactive oligodendroglial cell (d). In FRDA,
only lipofuscin (“L” in c) remains as an indicator of a nerve cell. This
neuron is negative with TUJ-1 and lacks juxtaneuronal ferritin-positive
oligodendroglia. Ferritin reaction product outlines vessel walls in (c).
The normal neuropil of the dentate nucleus displays not ferritin reac-
tion product in vessel walls (d). Double-label immunoXuorescence of
GFAP and ferritin: In e, an atrophic nerve cell with abundant lipofuscin
(L) is surrounded by numerous GFAP-positive astrocytic processes
(red), and vessel walls display the orange color of superimposed
GFAP (red) and ferritin (green). In the normal state (f), fewer astro-
cytic processes are present (red). They show no ferritin immunoreac-
tivity. Ferritin is conWned to a cell (arrow) and delicate processes in
close proximity to an intact neuron (N). L lipofuscin; N neuron; a, b,
paraYn sections; c–f vibratome sections. MagniWcation markers: a and
insets, 20 m; b 20 m; c–f 25 m123
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lipofuscin (L in Fig. 3c). Axons remain highly immunoreac-
tive with TUJ-1 (Fig. 3c). Ferritin reaction product also out-
lines vessel walls (Fig. 3c), which is not the case in the
normal dentate nucleus (Fig. 3d). Figure 3e, f combines
images of ferritin (FITC, green) and GFAP (DyeMer, red).
The image in Fig. 3e conWrms gliosis of the dentate nucleus
in FRDA and co-localization of GFAP and ferritin (yellow
merged image) in close apposition to vessel walls. In the
normal dentate nucleus, GFAP reaction product is less
prominent (Fig. 3f), and co-localization with ferritin around
blood vessels is absent. The dentate nucleus in FRDA or the
normal state yielded no reaction product with polyclonal
anti-mitochondrial ferritin [20].
Figure 4 shows ferroportin immunoreactivity in the cere-
bellar cortex (Fig. 4a1, a2, b1, b2), the white matter of the
folia (Fig. 4c, d), and the dentate nucleus (Fig. 4e, f). Pre-
incubation of the antiserum with a ferroportin-speciWc
peptide [11] or lysates of HEK239T cells over-expressing
ferroportin [11] eliminated the reaction. Lysates of
HEK239T cells transfected with empty vector had no eVect
on the Wnal reaction product. In promptly Wxed tissue, anti-
ferroportin visualizes Purkinje cell perikarya and dendrites,
including spiny branchlets. There are no obvious diVer-
ences in the dendrites of Purkinje cells in FRDA (Fig. 4a1)
when compared to the normal dentate nucleus (Fig. 4b1). In
FRDA, the granular layer shows occasional axonal expan-
sions (Fig. 4a2). Purkinje cell axons display dense reaction
product (Fig. 4b2). The white matter of the cerebellar folia
in FRDA and the normal state contain abundant ferropor-
tin-reactive axons (Fig. 4c, d). The most dramatic abnor-
mality in FRDA is grumose degeneration of the dentate
nucleus (Fig. 4e). Neurons are indistinct, and ferroportin
reaction product occurs in axons and irregular clusters
(Fig. 4e). In contrast, the normal dentate nucleus shows fer-
roportin reaction product in delicate synaptic terminals
abutting neurons (Fig. 4f). Figure 5a–f provides additional
immunocytochemical stains of grumose degeneration. The
clusters are reactive with anti-SNAP-25 (Fig. 5c) and anti-
mitochondrial complex V (FoF1¡) (Fig. 5e). All stains
show the disorganization of synaptic terminals undergoing
grumose degeneration in FRDA. Though ferroportin and
SNAP-25 immunoreactivity in grumose degeneration is
high, Fig. 5a, c also suggests an overall depletion of these
proteins in the neuropil between the patches of dense
reaction product.
Grumose degeneration does not always aVect the entire
dentate nucleus. It is most abundant when at least some
neuronal cell bodies persist (arrow in Fig 5a), and may be
absent in cases with total neuronal loss.
Antisera to DMT1+ and DMT1- conWrmed neuronal loss
in the dentate nucleus in FRDA patients (not illustrated).
Fig. 4 Ferroportin immunocy-
tochemistry in cerebellar cortex 
and dentate nucleus. Left panel 
(a1, a2, c, e), FRDA; right panel 
(b1, b2, d, f), normal. Ferropor-
tin reaction product is present in 
Purkinje cell perikarya and den-
drites, including spiny branch-
lets in FRDA (a1) and normal 
cerebellar cortex (b1). a2 shows 
a ferroportin-positive axonal tor-
pedo in the granular layer in 
FRDA. b2 The arrow indicates a 
ferroportin-reactive axon that 
arises from a Purkinje cell. 
Many white matter axons are 
ferroportin reactive (c FRDA, 
d normal). In the dentate nucleus 
of FRDA, multiple clusters of 
grumose degeneration display 
ferroportin reaction product (e). 
Neurons are absent. In the nor-
mal state (f), neurons are 
surrounded by delicate ferropor-
tin-reactive terminals supporting 
their origin from Purkinje cells. 
ParaYn sections; magniWcation 
markers: (a1–b2) 50 m; (c–f) 
20 m123
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sels in the atrophic nucleus that was attributed to shrinkage
of the neuropil (not illustrated).
Discussion
Iron and ferritin in the dentate nucleus of patients 
with FRDA
The dentate nucleus belongs to the iron-rich structures of
the brain [29] but sections of tissues obtained at autopsy
and stained by Perls’s method do not provide adequate cel-
lular localization of soluble non-heme iron. The reason is
delayed Wxation and release of iron from the main iron-carry-
ing protein, ferritin, during the interval between death and
immersion in formalin. In animal tissues Wxed by transcardiac
perfusion with aldehydes, iron and ferritin show a similar
cellular distribution. Ferritin is a large and relatively stable
protein that resists autolytic destruction, and processing
into paraYn sections does not destroy its antigenic determi-
nants. In the normal human dentate nucleus, ferritin is con-
centrated in juxtaneuronal cells (Fig. 3b, d) that lack aYnity
for RCA-1 and anti-CD45, excluding their derivation from
microglia. They have the appearance of satellite oligoden-
droglia and disappear when neurons become atrophic in
FRDA (Fig. 3c, e). The loss of these cells coincides with
the shift of ferritin immunoreactivity to microglia (Fig. 3a)
and astrocytic foot plates (Fig. 3c, e). Oligodendroglia in
the adjacent white matter are also intensely ferritin-positive
but this immunoreactivity does not change as FRDA pro-
gresses.
The results of total iron and holoferritin assays do not pro-
vide insight into the potential role of iron in the pathogenesis
Fig. 5 Immunostaining of grumose degeneration in FRDA. Left panel
(a, c, e), FRDA; right panel (b, d, f), normal. a, b ferroportin; c, d
SNAP-25; e, f mitochondrial complex V (FoF1-). All stains show se-
vere disorganization of the dentate nucleus in FRDA (a, c, e) when
compared to the normal state (b, d, f). Multiple clusters of grumose
degeneration in a are ferroportin-reactive, and the largest cluster lies
adjacent to a recognizable neuron (arrow). The clusters are also strong-
ly reactive for SNAP-25 (c) and mitochondrial complex V (e). The
normal dentate nucleus (b, d, f) shows ferroportin in terminals about
intact neurons and as granular reaction product throughout the normal
neuropil (b). SNAP-25 is present in densely packed axosomatic and
axodendritic terminals (d). The immunostain for mitochondrial com-
plex V shows dense reaction product in neuronal perikarya and peri-
neuronal granules that likely represent mitochondria in synaptic
terminals (f). ParaYn sections; magniWcation markers, (a–f) 20 m123
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to L-ferritin subunits is non-speciWc, and the observations
only conWrm what is known about general iron-handling in
mammalian tissues. Macro-staining for iron suggests a net
loss of the metal (Fig. 1a) but quantitative assays do not
conWrm reduced levels. Obviously, the dentate nucleus
aVected by FRDA retains total iron though it relocates it to
ferritin in microglia and astrocytes.
Immunocytochemical detection of ferritin has been used
for the identiWcation of microglia in various human brain
disorders [10, 15] but is probably less useful for “resting”
microglia. The number of microglia in sections of the nor-
mal human dentate nucleus is variable [16] but greater
abundance (Fig. 3a, upper inset) and hypertrophy (Fig. 3a,
lower inset) are probably associated with rapidly progres-
sive FRDA. The declining H/L ferritin subunit ratios in the
dentate nucleus in FRDA are the likely result of H-ferritin
subunit loss in oligodendroglia and increased L-ferritin sub-
unit biosynthesis in microglia. A similar shift to L-subunits
occurs in heart holoferritin of patients with FRDA [22].
Ferroportin in the dentate nucleus
In extracerebral tissues, ferroportin is now recognized as a
key protein in the export of iron from duodenal epithelial
cells, hepatocytes, and macrophages. It cannot be assumed
that this iron-carrying protein serves a similar function in
Purkinje cells and their processes (Fig. 4). Grumose degen-
eration of the dentate nucleus also occurs in two other com-
mon diseases of the CNS that are very diVerent from
FRDA, namely, spinocerebellar ataxia type 3 (SCA-3)/
Machado-Joseph disease (MJD) and progressive supranu-
clear palsy (PSP) [9, 13–14]. We examined ferroportin
immunoreactivity of grumose degeneration in three cases
of SCA-3/MJD and four cases of PSP. As expected, Pur-
kinje cells, corticonuclear Wbers, terminals, and regions of
grumose degeneration were ferroportin-reactive but gru-
mose degeneration in these diseases lacked the elaborate
ferroportin-reactive clusters of FRDA (Figs. 4e, 5a). Wu
et al. [32] localized ferroportin to synaptic vesicles by
immuno-electron microscopy, and their work is of immedi-
ate interest to the pathogenesis of grumose degeneration.
The authors suggested that the presence of an IRE in the
5-UTR of ferroportin mRNA makes synapses vulnerable
to iron toxicity. Neurons [2] and certain cells of the retina
[7] may utilize iron-responsive ferroportin translation as a
mechanism to eliminate iron toxicity. Synaptic terminals
contain abundant mitochondria, and the strong immunore-
activity of ferroportin in grumose degeneration of FRDA
may be an indicator of mitochondrial iron dysmetabolism
as reported for FRDA heart [22].
We propose that local iron excess in or near mitochon-
dria increases ferroportin biosynthesis by a translational
mechanism involving iron-regulatory proteins and an IRE
in the 5-UTR of the cognate mRNA. Under this assump-
tion, ferroportin is a putative marker for frataxin deWciency
in synaptic terminals of corticonuclear cerebellar Wbers.
Ferroportin is probably not relevant to the pathogenesis of
grumose degeneration in SCA-3/MJD and PSP.
Why do other iron-rich nuclei in the CNS not undergo
changes in FRDA? Sections of globus pallidus, substantia
nigra, red nucleus, and subthalamic nucleus show no ferro-
portin reaction product in perikarya or axons. Finely granu-
lar reaction product occurs in the neuropil and may be
located in synaptic terminals, resembling the positive stain-
ing of corticonuclear terminals in the normal dentate
nucleus. It is possible that the greater concentration of fer-
roportin in Purkinje cell-derived terminals makes them
more susceptible to iron dysmetabolism than synapses in
other CNS locations. The lack of reaction product in the
perikarya of neurons other than Purkinje cells in the human
CNS is at variance with observations in optimally Wxed rat
brain [23]. This discrepancy awaits clariWcation.
Trans-synaptic neuronal atrophy of the dentate nucleus
Over 60% of all corticonuclear cerebellar Wbers derive from
Purkinje cells, and atrophy of the dentate nucleus in FRDA
and other conditions displaying grumose degeneration may
be due to trans-synaptic atrophy. Though these clusters rep-
resent a peculiar and abnormal abundance of terminals, the
overall density of synapses in the dentate nucleus of
patients with FRDA and SCA-3/MJD is lower than normal
[18]. Primary Purkinje cell depletion in familial cortical
cerebellar atrophy readily explains synaptic loss in the den-
tate nucleus. In contrast, loss of synaptic terminals in
FRDA and SCA-3/MJD cannot be attributed to primary
Purkinje cell atrophy because the cerebellar cortex in these
ataxias is often entirely normal. Preservation of the inferior
olivary nuclei in FRDA and SCA-3/MJD conWrms that
climbing Wbers have normal targets, namely proximal Pur-
kinje cell dendrites. Why do Purkinje cells remain intact
while their terminals in the dentate nucleus degenerate? It is
known that axonal destruction does not necessarily cause
retrograde atrophy of Purkinje cells. These neurons have
much greater inherent resistance to axonal interruption than
other nerve cells whose eVerent Wbers begin and end within
the CNS [27]. The morphological preservation of Purkinje
cells in FRDA does not imply functional integrity, and the
deaVerentation of the dentate nucleus points to a primary
problem in Purkinje cells. In some cases of FRDA, these
nerve cells of the cerebellar cortex are abnormal, perhaps as
a small signal that a limited retrograde response to axonal
interruption does occur [12]. A logical extension of this
work is the search for ferritin aggregates at the ultrastruc-
tural level in the mitochondria of Purkinje cells and their123
172 Acta Neuropathol (2007) 114:163–173axons, and in regions of grumose degeneration. Bismuth
subnitrate enhancement of ferritin showed mitochondrial
inclusions with high electron density in cardiac mitochon-
dria of patients with FRDA [22], and this technique may be
equally suitable for brain tissue.
Iron as an in-vivo biomarker of FRDA
The normal total iron levels in the dentate nucleus in FRDA
reported here must be reconciled with magnetic resonance
measurements during life [31]. Waldvogel et al. [31]
reported that this neuro-imaging technique suggests a quan-
titative iron increase in the dentate nucleus of patients with
FRDA. Magnetic resonance imaging (MRI) may be mis-
leading because signal depression due to the paramagnetic
eVect of iron may also detect shifts of the metal into a
diVerent state, such as ferritin and hemosiderin, and into
more compact tissue in the course of atrophy (Fig. 1a). The
same amount of iron in a much thinner dentate nucleus will
cause a higher local concentration of the metal and presum-
ably a greater signal depression on T2-weighted images.
Nevertheless, MRI may become a useful monitor for indi-
vidual FRDA patients who receive experimental therapy.
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